ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Associations of Nephrosclerosis with Kidney Function and Size in Living Kidney Donors (LKD)

    E. Heaphy, Y. Ohashi, S. Nurko, B. Stephany, R. Fatica, H. Amer, A. Rule, J. Schold, E. Poggio

    Nephrology and HTN, Cleveland Clinic, Cleveland, OH; Nephrology and HTN, Mayo Clinic, Rochester, MN; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

    Despite their selection on health, LKD have been found to have subclinical nephrosclerosis. Identifying pre-donation characteristics that predict nephrosclerosis is of critical importance. We evaluated…
  • 2013 American Transplant Congress

    Clostridium difficile Infection in Lung Transplant Recipients during the Modern Era of PCR Testing

    J. Lee, D. Tsapepas, J. McDermott, S. Martin, A. Anamisis, K. Fester, J. Powell, J. Scheffert

    NewYork-Presbyterian Hospital, New York, NY

    Background: Solid organ transplant (SOT) recipients are at risk for Clostridium difficile infections (CDI) which occurs in up to 31% of lung transplant (LT) patients.…
  • 2013 American Transplant Congress

    Impact of Six Months Ciprofloxacin Prophylaxis on BK Viremia and BK Nephropathy, The

    M. Jason, W. Manitpisitkul, N. Wilson, J. Bromberg, S. Barlett, A. Haririan

    Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD; Department of Surgery, University of Maryland Medical Center, Baltimore, MD; Department of Medicine, University of Maryland Medical Center, Baltimore, MD

    Purpose: BK nephropathy is a serious complication after kidney transplantation and can ultimately lead to graft failure. Since fluoroquinolones inhibit BK DNA topoisomerase it has…
  • 2013 American Transplant Congress

    Impact of Post-Donation Body Weight Changes on Kidney Donor Blood Pressure, Kidney Function and Metabolic Parameters

    E. Heaphy, Y. Ohashi, B. Stephany, S. Nurko, R. Fatica, H. Amer, A. Rule, J. Schold, E. Poggio

    Nephrology and HTN, Cleveland Clinic, Cleveland, OH; Quatitative Health Sciences, Cleveland Clinic, Cleveland, OH; Nephrology and HTN, Mayo Clinic, Rochester, MN

    Obesity has been associated with chronic kidney disease and its risk factors. Therefore, we hypothesized that weight increase post-donation would adversely affect kidney function, blood…
  • 2013 American Transplant Congress

    Survival Benefits of Preemptive Renal Transplantation for Pediatric End Stage Renal Disease Patients

    B. Sayed, S. Amaral, N. Kutner, R. Patzer

    Department of Surgery, Emory University, Atlanta, GA; Department of Pediatrics, Department of Biostatistics and Epidemiology, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA; USRDS Rehabilitation/QoL Special Studies Center, Emory University, Atlanta, GA; Department of Epidemiology, Emory University, Atlanta, GA

    Kidney transplantation is the preferred treatment for pediatric end stage renal disease (ESRD), and preemptive transplantation may reduce morbidity and mortality. In the pediatric population,…
  • 2013 American Transplant Congress

    Residual Renal Function in Living Kidney Donors: Does Remaining Kidney Volume Matter?

    A. Diez, C. Sundaram, M. Mujtaba, T. Taber, M. Yaqub, D. Mishler, J. Powelson, W. Goggins, A. Sharfuddin

    Ohio State University, Columbus; IUH Transplant, Indiana University Health, Indianapolis

    Background:It is generally accepted that in living kidney donor nephrectomy for transplantation, the donor should remain with the larger kidney volume if possible. It has…
  • 2013 American Transplant Congress

    Psychiatric Outcomes of Liver Transplantation after Acetaminophen Overdose

    T. Dolenc, J. Bostwick, S. Jowsey, T. Schneekloth, T. Rummans

    Psychiatry and Psychology, Mayo Clinic, Rochester, MN

    Acetaminophen overdose is the leading cause of acute liver failure in the United States. A substantial proportion of these patients survive with conservative treatment. Liver…
  • 2013 American Transplant Congress

    Risk Factors for Graft Loss Due to BK Nephropathy: A Paired Kidney Analysis

    J. Gill, S. Hariharan, C. Rose, J. Dong, J. Gill

    Nephrology, University of British Columbia, Vancouver, BC, Canada; Transplantation, University of Pittsburgh Medical Center, Pittsburgh, PA

    The purpose of this case control study was to identify risk factors for transplant failure due to BK Nephropathy (BK).Using SRTR data from 1987-2011, we…
  • 2013 American Transplant Congress

    Long-Term Impact of Recipient and Donor Weight on Simultaneous Pancreas / Kidney (SPK) Graft Function

    A. Gruessner, R. Gruessner

    College of Public Health, University of Arizona, Tucson, AZ; Department of Surgery, University of Arizona, Tucson, AZ

    Introduction: Increased body weight in transplant patients has become a huge problem over the last years. Over the last decade only 52% of recipients and…
  • 2013 American Transplant Congress

    Significance of Preformed Donor Specific Antibodies (DSA) Detected by Highly Sensitive Solid Phase Assays: Prediction of Acute Antibody Mediated Rejection (AMR)

    D. Kannabhiran, J. Lee, R. Friedlander, D. Epstein, T. Muthukumar, J. Lee, M. Aull, A. Watkins, S. Kapur, V. Sharma, M. Suthanthiran, D. Dadhania

    Dept. of Transplantation Medicine, Weil Cornell- NYPH, NY, NY; IGT, Rogosin Institute, NY, NY

    Background:Luminex platform based solid phase antibody assays are used to identify unacceptable antigens for kidney transplant (Tx) candidates. Criteria for listing such unacceptable antigens varies…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences